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Successful parasitism of host cells by intracellular pathogens involves adherence, entry, survival, intracel-
lular replication, and cell-to-cell spread. Our laboratory has been examining the role of early events, adherence
and entry, in the pathogenesis of the facultative intracellular pathogen Legionella pneumophila. Currently, the
mechanisms used by L. pneumophila to gain access to the intracellular environment are not well understood.
We have recently isolated three loci, designated enh1, enh2, and enh3, that are involved in the ability of L.
pneumophila to enter host cells. One of the genes present in the enh1 locus, rtxA, is homologous to repeats in
structural toxin genes (RTX) found in many bacterial pathogens. RTX proteins from other bacterial species are
commonly cytotoxic, and some of them have been shown to bind to b2 integrin receptors. In the current study,
we demonstrate that the L. pneumophila rtxA gene is involved in adherence, cytotoxicity, and pore formation in
addition to its role in entry. Furthermore, an rtxA mutant does not replicate as well as wild-type L. pneumophila
in monocytes and is less virulent in mice. Thus, we conclude that the entry gene rtxA is an important virulence
determinant in L. pneumophila and is likely to be critical for the production of Legionnaires’ disease in humans.
Legionella pneumophila is an intracellular pathogen that
causes Legionnaires’ disease in humans, a potentially lethal
pneumonia. The ability of L. pneumophila to enter, survive,
and replicate in monocytic cells is essential for pathogenesis.
Differences in the mechanisms used to enter monocytes cor-
relate with subsequent intracellular survival and replication
(13). In addition, it has recently been shown that the bacterial
entry mechanism and/or factors expressed very early after en-
try alter intracellular trafficking (52). L. pneumophila has been
shown to enter monocytes by an unusual mechanism, coiling
phagocytosis (28), in addition to the conventional phagocytic
mechanism observed in most other bacterial species. Although
coiling phagocytosis also occurs in spirochetes (12, 47, 48), the
bacterial factors and host cell components involved are not
known. Complement (31, 40, 45) and antibody (30, 31) opson-
ization have effects on adherence of L. pneumophila to mono-
cytes. In addition, growth conditions (14) and opsonization
with complement (13) or antibodies (28) have been shown to
affect the frequencies of coiling and conventional phagocytosis.
However, both complement (13) and antibody (28) opsoniza-
tion results in higher frequencies of conventional phagocytosis.
Furthermore, conventional phagocytosis correlates with lower
replication rates of L. pneumophila in monocytes (13). These
data suggest that further study of the mechanisms of nonop-
sonic phagocytosis by monocytes is critical to obtaining a better
understanding of L. pneumophila pathogenesis.
Our laboratory has recently identified three chromosomal
loci, designated enh1, enh2, and enh3, that affect nonopsonic
entry of L. pneumophila into monocytes (15). These loci are
different from the loci that encode the type IV pilus (58) and
major outer membrane protein (38) previously shown to play
roles in nonopsonic adherence to and entry into monocytes,
respectively. One of the genes present in the enh1 locus, des-
ignated rtxA, encodes a “repeats in structural toxin” (RTX). A
cytotoxic activity previously observed in L. pneumophila (32)
displayed characteristics reminiscent of RTX proteins, includ-
ing a bacterial surface-associated cytotoxic activity. Since RTX
proteins from Bordetella (24) are involved in adherence to host
cells and colonization of host epithelium, the rtxA gene is a
likely candidate for an L. pneumophila entry gene. RTX pro-
teins from several other species, including Actinobacillus acti-
nomycetemcomitans (39) and Escherichia coli (8), have the
ability to bind specifically to host cells. Adherence of RTX
proteins to host cells is thought to be mediated by b2 integrins
(1, 39). Since complement receptors are b2 integrins, these
data fit well with studies demonstrating that anti-complement
receptor antibodies inhibit adherence to and entry into mono-
cytes by L. pneumophila (40, 45), though these studies were
done in the presence of complement.
In order to better characterize the role of rtxA in adherence
and pathogenesis, we characterized the phenotype of an
L. pneumophila strain containing an in-frame deletion in this
gene. The resulting mutant strain displayed significantly re-
duced adherence, cytotoxicity, pore formation, intracellular
replication, and virulence in mice compared to wild-type
L. pneumophila.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The L. pneumophila strain used for
these studies was the streptomycin-resistant variant (43) of L. pneumophila
serogroup 1 strain AA100 (20). This strain has been shown to be virulent in both
in vitro and in vivo models of infection (43) and was passaged no more than twice
in the laboratory before use in these studies. The L. pneumophila rtxA in-frame
deletion mutant strain Clp24 (DrtxA) has been described previously (15). L.
pneumophila strains were grown on BCYE agar (19) for 3 days at 37°C in 5%
CO2 as described previously (13). The E. coli K-12 strain Cec47, used for
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propagation of R6K ori plasmids (XL1-Blue [Stratagene] lysogenized with lpir),
was grown in Lennox broth (Difco Laboratories) at 37°C. When necessary,
kanamycin (Sigma) was added at a concentration of 25 mg/ml, NaCl was added
at 5 mg/ml, and sucrose was added at 50 mg/ml to bacterial growth media.
Cell culture. HEp-2 cells (ATCC CCL23), established from a human epider-
moid carcinoma, were grown in RPMI 1640 plus 5% heat-inactivated fetal calf
serum (Gibco). THP-1 (ATCC TIB202) and U-937 cells (ATCC CRL1593.2),
both human monocytic cell lines, were grown in RPMI 1640 plus 10% heat-
inactivated fetal calf serum. RAW264.7 (ATCC TIB71) and J774A.1 (ATCC
TIB67), both murine cell lines, were grown in Dulbecco’s modified Eagle’s
medium plus 10% heat-inactivated fetal calf serum.
Molecular techniques and plasmid construction. Previous studies in our lab-
oratory demonstrated that the rtxA gene affects entry into epithelial cells (Hep-2)
and monocytes (THP-1) (15). In the current study, the wild-type L. pneumophila
strain AA100, the DrtxA mutant, and complementing strains were examined for
other phenotypic characteristics that may help to determine whether rtxA plays
a role in virulence. The structure of the in-frame deletion in rtxA and the
constructs used for complementation are shown in Fig. 1. Both single-copy and
multicopy complementation constructs were used to control for enhanced ex-
pression of rtxA due to copy number effects. To ensure physiologically normal
RtxA levels for complementation, we expressed rtxA from its endogenous pro-
moter in the same position as it is found in the L. pneumophila chromosome.
Since sequence analysis of the rtxA region suggests that the gene is the second in
an operon of two genes (15), we utilized complementing constructs that contain
the entire operon and putative promoter (pJDC20 and pJDC35). In order to
determine whether complementation is solely due to the presence of the rtxA
gene on this construct, an identical construct without rtxA was also used
(pJDC40). The combination of these constructs allows definitive demonstration
of the activity of the rtxA gene under conditions that are as close as possible to
those that naturally occur in the L. pneumophila chromosome.
DNA manipulations were carried out essentially as described previously (53).
The construction of the DrtxA mutant has been described previously (15). The
complementation plasmid pJDC20 (Fig. 1) carries the EcoRI fragment that
contains only the enh1 locus with rtxA and putative promoter region (15). The L.
pneumophila suicide plasmid pJDC35 (Fig. 1) was constructed by insertion of this
same EcoRI fragment into the EcoRI site of pJDC15 (15). The L. pneumophila
suicide plasmid pJDC40 (Fig. 1) was constructed by digestion of pJDC35 with
SwaI and EcoRV followed by self-ligation. Both pJDC35 and pJDC40 were
propagated in Cec47 prior to transformation into L. pneumophila. These plas-
mids can only be maintained by integration into the L. pneumophila chromosome
via homologous recombination. The presence of the appropriate integrated
plasmid was confirmed by Southern and PCR analysis of chromosomal DNA
from the resulting strains (data not shown) as described previously (15).
Phenotypic characterization of strains. The presence of pili and flagella on the
Drtx mutant and wild-type L. pneumophila strains was assessed by transmission
electron microscopy of negatively stained specimens as described previously (15).
Ultrastructural morphology of these strains was examined as described previ-
ously (14, 15). Motility was assessed using microscopy (15). Sodium sensitivity
FIG. 1. Structure of the rtxA region, DrtxA mutant, and complementing constructs. All constructs are in single copy in the L. pneumophila
chromosome except pJDC20, which is present in the low-copy-number (26) plasmid pYUB289 (3, 15). The DrtxA mutant carries an in-frame
deletion in the rtxA gene, producing a 130-amino-acid protein product, consisting of 6 amino acids from the amino terminus and 124 amino acids
from the carboxy terminus. Gene designations are below the arrows on the constructs illustrating the direction of transcription of the genes. Open
boxes in AA100 indicate the positions of the 9-amino-acid repeat sequences characteristic of RTX proteins.
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was measured by plating dilutions of each strain on BCYE agar and BCYE agar
plus 100 mM NaCl and determining colony-forming units (CFU) as described
previously (11). The level of sodium sensitivity was expressed as a percentage of
the titer in the presence of sodium and compared to that of the wild type.
Osmotic sensitivity was measured as described previously (11). Complement
sensitivity was examined by incubating 108 CFU of each strain in RPMI contain-
ing 50% complete or heat-inactivated human serum for 10 min at 37°C, followed
by plating dilutions on BCYE agar to determine CFU. A particular strain was
considered sensitive to complement if it displayed a significant decrease in CFU
in the presence of complete serum compared to heat-inactivated serum or prior
to incubation with serum. Conjugation frequencies were determined essentially
as described previously (56) except that pJDC1 (15) was used as the donor
plasmid and a naturally arising rifampin-resistant AA100 strain was used as the
recipient. Growth rate in laboratory media was determined as described previ-
ously (11, 15).
Adherence assays. Adherence assays were carried out by the immediate assay
method described previously (13, 14). HEp-2 cells were seeded in 24-well tissue
culture dishes (Falcon) at a concentration of 1.5 3 106 cells/well and allowed to
adhere overnight at 37°C. After adding the bacteria, the medium was gently
mixed by rocking back and forth, immediately washed five times with phosphate-
buffered saline (PBS) to remove nonadherent bacteria, and then lysed by incu-
bation for 10 min in 1 ml of water followed by vigorous pipetting. Although we
tested multiple multiplicities of infection (MOIs) (1, 10, and 100) in these
experiments, all data shown are for an MOI of 10. Within this range, the MOI did
not significantly affect the data obtained. In the case of THP-1 cells, the assays
were carried out in suspension. This requires that the cells be pelleted by
centrifugation at 100 3 g for 1 min before each change of solution. After lysis, the
number of cell-associated bacteria was determined by plating for CFU on BCYE.
Adherence assays on formaldehyde-fixed cells (23) were carried out in the same
manner except that the cells were fixed in 3.7% formaldehyde for 10 min, washed
three times with PBS, and suspended in RPMI prior to addition of the bacteria.
For formaldehyde-fixed cells, the bacteria were coincubated with the cells for 30
min (THP-1 cells) or 90 min (Hep-2 cells). Adherence levels were determined by
calculating the percentage of the inoculum that became cell associated over the
course of the assay [i.e., % adherence 5 100 3 (CFU cell associated/CFU in
inoculum)]. For the wild-type bacterial strain AA100, adherence averaged ap-
proximately 0.004% to THP-1 cells and 0.06% to Hep-2 cells under these assay
conditions in both formaldehyde-fixed and untreated cells. In order to correct for
variation in levels of uptake between experiments, adherence is reported relative
to AA100 (i.e., relative adherence 5 % adherence of test strain/% adherence of
AA100).
Intracellular growth assays. The 48-h growth assays were carried out in a
manner similar to that described elsewhere (67). The THP-1 cells used for
growth assays were seeded into 24-well tissue culture dishes at 1.5 3 106 cells/
well in RPMI plus 10% serum and activated with gamma interferon and lipo-
polysaccharide (LPS; Difco; E. coli O127:B8) as described previously (13).
THP-1 cells treated with gamma interferon and LPS were used in these assays
because in our previous studies they were found to be more sensitive to differ-
ences in the levels of L. pneumophila virulence than resting monocytes (13).
However, activated THP-1 cells were only used for intracellular growth assays
because their increased constitutive phagocytic activity makes them a poor
choice for use in adherence and entry assays, as illustrated by an increase in the
uptake of noninvasive E. coli strain HB101 compared to invasive L. pneumophila
strains in adherent monocytic cells (14). For 48-h growth assays, bacteria were
added to the cells and incubated at 37°C for 1 h, washed multiple times with
warm PBS, and suspended in fresh medium for 48 h before lysis with water.
Detailed growth assays were carried out as described previously (13). In these
assays the bacteria were incubated with the host cells for 5 min and then treated
in the same manner as for the 48-h assays with lysis at various times after
washing. Dilutions of the resulting lysates were plated on BCYE agar to deter-
mine CFU immediately after the washes and at each time point. All assays were
carried out using an MOI of 10. Growth is reported as the mean number of CFU
present in triplicate samples at various times divided by the number of CFU
present immediately after washing (mean CFU Tx/T0). Under these experimental
conditions, AA100 regularly displays between 500 and 1,000 CFU/ml in detailed
growth assays and between 10,000 and 50,000 CFU/ml in 48-h growth assays at
T0.
Cytotoxicity and pore formation assays. The standard lactate dehydrogenase
release cytotoxicity assay (5, 9) was used in these studies. The procedure used
was essentially as recommended by the manufacturer of the CytoTox96 non
radioactive cytotoxicity assay system (Promega). Serial dilutions were made of
each bacterial strain at MOIs of 500, 250, 100, and 10 in a final volume of 100 ml
for each assay using 2 3 104 THP-1 or 2.5 3 103 Hep-2 cells. Appropriate
numbers of cells for CytoTox96 assays were determined as suggested by the
manufacturer (Promega). The cells were incubated with the bacteria for 4 h at
37°C with 5% CO2. Cytotoxicity readings were taken using an enzyme-linked
immunosorbent assay plate reader at 450 nm. Percent cytotoxicity was calculated
as recommended by the manufacturer and corrected for small differences in the
inocula used.
Formation of pores in host cells was assayed by ethidium bromide and acridine
orange staining exactly as described previously (37, 67) using THP-1, U-937,
RAW264.7, J774A.1, and Hep-2 cells. Stained coverslips were examined using a
Nikon TE300 inverted microscope with fluorescein isothiocyanate and tetra-
methyl rhodamine isothiocyanate filters. Dual images of multiple fields were
captured using an Optronics charge-coupled device video camera and analyzed
as described previously (67). Pore formation is expressed as the percentage of
acridine orange-stained cells that also stain with ethidium bromide, resulting
from incorporation of this dye into chromosomal DNA due to increased perme-
ability of the host cell. All cells are stained with acridine orange since, unlike
ethidium bromide, acridine orange readily crosses the membranes of eukaryotic
cells.
Mouse infections and examination for pathology. In order to examine the
virulence of the different L. pneumophila strains in mice, we used methods
described previously (6, 10, 13). A/J mice were infected by intratracheal inocu-
lation with 106 bacteria. The mice were harvested 1, 4, 24, and 48 h after
infection, and bacteria in the lungs were quantitated as described previously (6,
10, 13). Data represent the mean CFU and standard deviation per gram of lung
from 12 mice in each experimental group. All preparations were suspended in
PBS prior to inoculation.
Histopathology examination was conducted essentially as described previously
(10, 43). Lungs were fixed by immersion in 10% neutral phosphate-buffered
formalin, processed routinely, embedded in paraffin, cut at 5 mm, and stained
with hematoxylin and eosin. L. pneumophila in sections was detected through the
use of Warthin-Starry silver stain (36, 43). Each section was assigned a number
code to allow blinded examination by light microscopy.
Statistical analyses. All in vitro experiments were carried out in triplicate and
repeated three times. The experiments in vivo were carried out using 12 mice per
experimental group. The significance of the results was analyzed using analysis of
variance. Values of P of ,0.05 were considered significant.
RESULTS
rtxA affects adherence to monocytes and epithelial cells. The
entry mechanism used by L. pneumophila may be the result of
interaction of the host cell with the bacteria at the level of
adherence, entry, or a combination of these two events. The
rtxA gene has previously been shown to have a twofold effect
on entry into monocytes (THP-1) and epithelial (HEp-2) cells,
but adherence and other phenotypic characteristics potentially
related to virulence have not been examined (15). The sodium,
osmotic, and complement sensitivity of the DrtxA mutant was
not significantly different from that of wild-type L. pneumo-
phila (data not shown). Furthermore, there were no differences
in the presence of pili, presence of flagella, ultrastructure,
conjugation frequency, or motility of the DrtxA mutant com-
pared to wild-type bacteria (data not shown). The lack of any
other obvious phenotype in vitro suggests that the primary
defect in the DrtxA mutant is in its ability to enter host cells.
In order to ascertain the role of adherence in rtxA-mediated
entry, we examined the adherence of the rtxA mutant to epi-
thelial and monocytic cells (Fig. 2). Adherence to both cell
types was reduced by approximately 50% in the rtxA mutant
compared to wild-type L. pneumophila. In contrast, levels of
adherence similar to wild-type levels were observed in the rtxA
mutant carrying a complementing construct containing the
complete rtxA gene. However, the rtxA mutation could not be
complemented by the same construct containing the putative
promoter region and complete arpB gene in the absence of
rtxA. All strains were tested for sensitivity to assay conditions
such as osmotic lysis, culture medium, and serum. No signifi-
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cant differences were observed between the DrtxA and wild-
type strains. These data suggests that the rtxA gene is involved
in adherence of L. pneumophila to epithelial and monocytic
cells.
Although adherence assays are carried out quickly to pre-
vent the possibility of intracellular killing by the host cell, we
initially felt that it was possible that some portion of the dif-
ference in adherence observed is due to effects on survival after
internalization. In order to test this possibility, we examined
the adherence of the rtxA mutant to formaldehyde-fixed epi-
thelial and monocytic cells (Fig. 3), in which internalization
cannot occur. Similar differences were observed between the
rtxA mutant and wild-type L. pneumophila strains. Both assay
methods result in nearly all bacteria remaining extracellular
(99.7 to 99.9%), where they are killed by gentamicin (data not
shown). Thus, both assay methods are sufficient to allow eval-
uation of the role of rtxA in adherence, and killing subsequent
to uptake does not contribute significantly to the data ob-
tained. This information suggests that the preferred assay for
adherence of L. pneumophila would be the immediate assay,
since it results in nearly all bacteria remaining extracellular and
is unlikely to have aberrant affects on the host cell.
rtxA affects cytotoxicity and pore formation caused by L.
pneumophila. One common characteristic of RTX proteins
from other bacterial species is their involvement in pore-form-
ing cytotoxicity for eukaryotic cells (62). Genes involved in
pore-forming cytotoxicity have recently been associated with
the ability of L. pneumophila to replicate intracellularly (37,
61). Thus, the rtxA gene is a potential mediator of the cytotox-
icity and/or pore formation associated with L. pneumophila
infection. When we examined the role of rtxA in cytotoxicity,
we found that the DrtxA mutant displayed less cytotoxicity for
monocytic cells than the wild type (Fig. 4). The level of cyto-
toxicity observed in wild-type L. pneumophila (;35%) was less
FIG. 2. Ability of AA100, the DrtxA mutant (DrtxA), and comple-
mented clones to adhere to HEp-2 epithelial cells (A) and THP-1
monocytic cells (B). Data points and error bars represent the means of
triplicate samples from a representative experiment and their standard
deviations, respectively. All experiments were performed at least three
times.
FIG. 3. Ability of AA100, the DrtxA mutant (DrtxA), and comple-
mented clones to adhere to formaldehyde-fixed HEp-2 epithelial cells
(A) and THP-1 monocytic cells (B). Data points and error bars rep-
resent the means of triplicate samples from a representative experi-
ment and their standard deviations, respectively. All experiments were
performed at least three times.
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than that observed previously (;65%) using a similar assay
(37). These differences are likely due to differences in the cell
lines (bone marrow-derived murine macrophages versus
THP-1 human monocytes) and bacterial strains (Lp02 versus
AA100) used. No cytotoxicity was observed for the epithelial
cell line HEp-2 with the wild-type or rtxA mutant strain (data
not shown). These data suggest that the cytotoxicity of L.
pneumophila is at least somewhat specific for monocytes. How-
ever, the fact that rtxA affects cytotoxicity is not necessarily
directly related to the pore formation previously observed dur-
ing L. pneumophila infection of monocytes.
In order to determine the role of rtxA in pore formation, we
compared the pore-forming ability of wild-type L. pneumophila
with that of the rtxA mutant and complemented clones in four
different monocytic cell lines (Fig. 5). We utilized both human
and murine cells for these assays to determine whether the
pore-forming activity was species specific, as is sometimes ob-
served with RTX proteins from other bacterial species (4, 25,
50, 57, 59, 60). Our data indicate that rtxA is involved in a
pore-forming activity that occurs in both murine and human
monocytes. Although the level of pore formation varies in
different cell types, pore formation is consistently reduced in
the rtxA mutant compared to the wild type and correlates with
increased bacteria-per-cell ratios. The smallest difference is
observed in RAW264.7 cells, a mouse macrophage cell line,
though this difference is still significant (P 5 0.043). No pore
formation was observed in HEp-2 cells with wild-type L. pneu-
mophila or the rtxA mutant (data not shown). These data
indicate that the L. pneumophila rtxA gene is involved in a
cytotoxic and pore-forming activity affecting both human and
murine monocytic cells but not HEp-2 cells.
Optimal intracellular survival and replication require rtxA.
Since pore formation is thought to be involved in the intracel-
lular survival of L. pneumophila (37, 61), the activities that are
associated with rtxA may also affect intracellular viability. In
order to elucidate whether rtxA plays an important role early
during intracellular infection, we compared the ability of the
DrtxA mutant to survive and replicate in monocytes. Although
the DrtxA mutant replicates like the wild type in BYE broth
(data not shown), growth in monocytes is significantly lower
during the first 48 h of growth (Fig. 6). In order to examine
the intracellular viability of L. pneumophila at very early time
points during intracellular growth, we used a 5-min coincuba-
tion with host cells. This procedure allowed detailed examina-
tion of the kinetics of intracellular growth from 5 min to 48 h
(Fig. 7). These data demonstrate that the DrtxA mutant ap-
pears to be killed more efficiently in monocytes during the first
2.5 h after uptake. The apparent difference between the fold
increase observed in Fig. 6 and 7 is due to the different time
zero used (1 h as opposed to 5 min) along with the rapid
intracellular killing observed at early time points during intra-
cellular growth. Taking these two factors into consideration,
the data are consistent with AA100 increasing from approxi-
mately 0.1 to 6 (60-fold) and DrtxA increasing from approxi-
mately 0.05 to 2 (40-fold) over 48 h. The early intracellular
killing of the DrtxA mutant suggests that the effects of rtxA on
entry affect intracellular viability. This early defect in intracel-
lular survival leads to continuously lower intracellular replica-
tion, even at time points as late as 48 h.
rtxA affects virulence. Since the differences between the
DrtxA and wild-type strains are relatively small in these in vitro
assays, we wished to determine whether these small differences
in phenotype significantly affect the ability of L. pneumophila
to cause disease. In order to elucidate whether the phenotypic
effects observed in vitro correlate with changes in virulence, we
compared the ability of the wild-type, DrtxA mutant, and com-
plemented strains to infect mice (Table 1). Although the initial
of bacteria found in the lung 1 h after infection is similar for all
strains, the CFU for the DrtxA mutant decrease over time. By
24 h after infection, there is a 10-fold difference in CFU be-
tween the DrtxA mutant and the wild type, whereas there was
no significant difference between the single-copy comple-
mented strain (DrtxA::pJDC35) and the wild type at any time
point. This corresponds well with our observation that the
DrtxA mutant displays reduced intracellular survival in mono-
cytes. Interestingly, the CFU for the DrtxA mutant containing
the multicopy plasmid pJDC20 increase more quickly than for
the wild type, suggesting that the increased copy number of this
region enhances the ability of L. pneumophila to survive and/or
replicate in mouse lungs.
Throughout the course of these experiments, the animals
were monitored for signs of disease. At 1 h after infection, no
mice displayed any adverse symptoms. However, by 48 h all of
the mice infected with the wild type (AA100) and DrtxA::pJDC20
mutant and the majority of the mice infected with the DrtxA::
pJDC35 mutant displayed malaise and ruffled fur, whereas
only one mouse infected with the DrtxA mutant showed mal-
aise. Histopathologic examination of lungs from mice infected
with these strains (Fig. 8) confirmed the disease state of the
mice in each group and showed characteristics similar to those
found in previous studies on L. pneumophila infections in mice
(10). Lung tissue from mice infected with wild-type AA100,
DrtxA::pJDC20, and DrtxA::pJDC35 strains displayed lesions
consisting of lobular areas of parenchymal consolidation char-
acterized by severe suppurative inflammation together with
peribronchial and perivascular interstitial edema. Infiltration
FIG. 4. Cytotoxicity of AA100, the DrtxA mutant (DrtxA), and
DrtxA transformed with pJDC20, pJDC35, and pJDC40 for human
monocytic cell line THP-1. Data points and error bars represent the
means of triplicate samples from a representative experiment and their
standard deviations, respectively. All experiments were performed at
least three times.
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by mixed inflammatory cells, primarily polymorphonuclear
neutrophils, was also observed. Large clusters of leukocytic
exudate mixed with necrotic cellular debris and red blood cells
are present in bronchiolar lumena and extend to the surround-
ing alveolar air spaces. However, the respiratory mucosa re-
main intact. Silver stain sections from mice infected with the
wild-type strain display small clusters of apparently intracellu-
lar rod-shaped organisms in mononuclear inflammatory cells
present within affected alveolar lumena (Fig. 8). In contrast,
lung tissues from mice infected with the DrtxA and DrtxA::
pJDC40 mutant are negative for lesions, and bacteria are often
extracellular and less abundant throughout the sections. These
data indicate that the rtxA gene is a key virulence determinant
and that the mechanism of entry used is likely to be critical to
L. pneumophila pathogenesis.
DISCUSSION
Monocytes utilize a number of relatively nonspecific mech-
anisms to phagocytose particles, including LPS- (54), surfac-
tant- (51), Fc- (7, 18, 29, 44), complement- (18, 45, 51, 55), and
mannose-mediated (33) mechanisms. In addition, pathogens
can trigger specific mechanisms to enter monocytes (16, 46,
49). However, little is known about the effects of different entry
mechanisms on subsequent intracellular viability of pathogens.
We are interested in determining the effects of different entry
mechanisms on the pathogenesis of L. pneumophila. Through
the identification of the L. pneumophila genes involved in entry
and characterization of their role in the establishment of a
preferred intracellular niche and production of disease, we
hope to improve our understanding of the importance of dif-
ferent entry mechanisms. This information is likely to lead to
FIG. 5. Pore formation by AA100, the DrtxA mutant (DrtxA), and DrtxA transformed with pJDC20, pJDC35, and pJDC40 for THP-1 (A), U-937
(B), RAW264.7 (C), and J774.1 (D) cells. Data points and error bars represent the means of triplicate samples from a representative experiment
and their standard deviations, respectively. All experiments were performed at least three times. EtBr, ethidium bromide.
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novel methods for prevention of the disease process prior to
invasion, the first step in pathogenesis, before an infection
can become well established. The rtxA gene was initially
identified because of its role in entry (15). However, in the
current study we demonstrate that this gene also affects a
number of other phenotypic characteristics potentially asso-
ciated with pathogenesis, including virulence in mice. Fur-
ther studies are necessary to determine whether the ob-
served phenotypic effects on adherence, entry, cytotoxicity,
pore formation, intracellular growth, and virulence are due
to the direct involvement of rtxA or indirect effects on other
bacterial factors.
Although the rtxA gene affects adherence to epithelial cells,
it is more critical for adherence to monocytes. This observation
may provide some insight into the potential host cell receptors
involved. The b2 integrin receptor has been shown to be a
receptor for RTX proteins from other bacteria (1, 39). Thus, if
RtxA binds to a similar receptor, our results may be explained
by the fact that epithelial cells normally express much lower
levels of b2 integrins than monocytic cells (21, 42). Although
the current study does not examine the receptors involved, this
model fits well with previous data demonstrating a role for
complement receptors in adherence and entry (40, 45). The
absence of observable pore formation and cytotoxicity in
HEp-2 cells may also be due to the potential involvement of b2
integrins in these events. It is intriguing to speculate that the
lack of rtxA cytotoxicity for epithelial cells may help to explain
the histopathological observation of the maintenance of an
intact respiratory mucosa in the presence of a severe inflam-
matory response. This pathologic observation is consistent with
previous studies on L. pneumophila infections in guinea pigs
(34, 64). However, many additional experiments are neces-
sary to clearly demonstrate that the RtxA is involved in a
mechanism of entry that occurs via b2 integrins. The DrtxA
mutant isolated in the current studies should greatly facili-
tate further research into the role of host cell receptors and
signaling pathways in L. pneumophila adherence and entry
mechanisms.
It is possible that all of the other phenotypic characteristics
that are associated with the DrtxA mutation are related to
adherence and/or entry. Hypothetically, the mechanism of en-
try triggered by rtxA could result in signaling events that affect
intracellular trafficking. These effects may be responsible for
the ability of L. pneumophila to inhibit lysosomal fusion (27,
52). Thus, the role of rtxA in intracellular survival may be
explained through effects on trafficking. Examination of the
intracellular trafficking of the DrtxA mutant after uptake into
monocytes should allow us to obtain a better understanding of
the role of the rtxA gene in pathogenesis. It has been shown
that L. pneumophila replicates primarily within monocytes dur-
ing disease (17, 22, 41, 65). Although the phenotypic effects of
DrtxA in vitro were relatively small, the effects in vivo were
FIG. 6. Growth of AA100, the DrtxA mutant (DrtxA), and DrtxA
transformed with pJDC20, pJDC35, and pJDC40 in THP-1 cells over
48 h. Data points and error bars represent the mean number of CFU
present at 48 h/number of CFU present at time zero (mean CFU
Tx/T0) of triplicate samples from a representative experiment and their
standard deviations, respectively. All experiments were performed at
least three times.
FIG. 7. Growth of AA100 and the DrtxA mutant (DrtxA) in THP-1
monocytic cells during the first 24 (A) and 48 (B) h after entry. Data
points and error bars represent the means of triplicate samples from a
representative experiment and their standard deviations, respectively.
Many of the error bars are not visible because they overlap the sym-
bols. All experiments were performed at least three times.
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quite obvious. These data suggest that subtle defects in the
ability of L. pneumophila to enter, survive, and replicate in
monocytes may dramatically affect the ability to survive in vivo.
This is not surprising, considering that all of the components of
the host immune system are available in vivo to combat infec-
tions. This phenomenon is particularly likely in immune cells
such as monocytes, in which proper lymphokine modulation is
important for the prevention of intracellular infections. In the
absence of a complete understanding of the factors involved in
the proper modulation of the bactericidal activity of mono-
cytes, we cannot duplicate these conditions in vitro. These data
suggest that it is important to carefully examine potential vir-
ulence determinants in vitro for subtle defects and underscore
the importance of virulence studies in animal models, where
the selection for optimal pathogen-host cell interactions may
be more stringent.
The effects of rtxA on adherence may be directly responsible
for the defect in the persistence of the DrtxA mutant in mouse
lungs. However, it is equally possible that the rtxA gene has
dual functions, adherence and pore formation, both of which
may be important for the pathogenesis of L. pneumophila.
Proper intracellular trafficking, cytotoxicity, and prevention of
lysosomal fusion by L. pneumophila are thought to be due to a
pore-forming activity involving a type IV secretion apparatus
(37, 52, 61, 63). Since RTX proteins are known to cause pore
formation in host cells (62), it is possible that the rtxA gene
product is responsible for this activity. Our observation of a
pore-forming activity that requires the presence of the rtxA
gene supports this hypothesis. However, it is unlikely that rtxA
is solely responsible for the cytotoxicity associated with the
dot/icm complex, since an rtxA mutation only partially reduces
cytotoxicity (;37% reduction), whereas dot/icm mutations
more significantly reduce cytotoxicity (;62% reduction) (37).
Furthermore, additional cytotoxic (2, 35) and hemolytic (35,
66) proteins are known to be produced by L. pneumophila. It
should be possible to construct a conditional mutant to mod-
ulate the rtxA phenotype in order to determine whether this
gene has dual functions or whether its effects on entry are
sufficient to cause the other phenotypic effects observed. How-
ever, the rtxA gene is clearly involved in adherence to and entry
into monocytes and is critical for the ability of L. pneumophila
to survive and replicate in vivo.
FIG. 8. Histopathologic examination of mouse lungs 48 h after infection with wild-type (B and D) and the rtxA mutant (A and C) L.
pneumophila strains. Lung sections were stained with hematoxylin and eosin (A and B) or Warthin-Starry silver stain (C and D). (B) Characteristic
example of a mouse lung infected with wild-type L. pneumophila, displaying severe peribronchial pneumonia with leukocytic exudate, necrotic
debris, and red blood cells within two small bronchioles. (A) In striking contrast, lungs infected with the DrtxA mutant displayed characteristics
similar to those of normal healthy mouse lungs, with clear bronchioles and alveoli showing very little or no inflammatory infiltrate. Silver-stained
sections (C and D) allowed visualization of bacteria (arrows). Magnification: (A and B) 3400, (C and D) 31,000.
TABLE 1. Replication of L. pneumophila in lungs after intratracheal inoculationa
Time after
infection
(h)
Mean bacteria (CFU/g of lung) 6 SD
AA100 DrtxA DrtxA::pJDC20 DrtxA::pJDC35 DrtxA::pJDC40
1 4.1 (6 0.3) 3 104 4.9 (6 0.3) 3 104 8.4 (6 0.2) 3 104 2.4 (6 0.3) 3 104 3.5 (6 0.2) 3 104
4 6.5 (6 0.3) 3 104 6.1 (6 0.2) 3 104 1.9 (6 0.2) 3 105* 5.9 (6 0.3) 3 104 3.1 (6 0.2) 3 104
24 8.3 (6 0.4) 3 104 5.8 (6 0.3) 3 103* 2.6 (6 0.4) 3 106* 6.4 (6 0.3) 3 104 8.4 (6 0.3) 3 103*
48 1.9 (6 0.2) 3 105 1.6 (6 0.2) 3 102* 1.2 (6 0.3) 3 107* 8.1 (6 0.3) 3 104 1.2 (6 0.4) 3 103*
a An inoculum of 106 bacteria was used for all experimental groups. Data represent the means 6 standard deviations of duplicate platings from 12 mice. p, significantly
different (P , 0.05) from wild-type L. pneumophila (AA100).
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48. Rittig, M. G., A. Krause, T. Häupl, U. E. Schaible, M. Modolell, M. D.
Kramer, E. Lütjen-Drecoll, M. M. Simon, and G. R. Burmester. 1992. Coil-
ing phagocytosis is the preferential phagocytic mechanism for Borrelia burg-
dorferi. Infect. Immun. 60:4205–4212.
49. Robledo, S., A. Wozencraft, A. Z. Valencia, and N. Saravia. 1994. Human
monocyte infection by Leishmania (Viannia) panamensis: role of comple-
ment receptors and correlation of susceptibility in vitro with clinical pheno-
type. J. Immunol. 152:1265–1276.
516 CIRILLO ET AL. INFECT. IMMUN.
50. Rosendal, S., J. Devenish, J. I. MacInnes, J. H. Lumsden, S. Watson, and H.
Xun. 1988. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic ac-
tivity of Haemophilus (Actinobacillus) pleuropneumoniae. Am. J. Vet. Res.
49:1053–1058.
51. Rosseau, S., A. Guenther, W. Seeger, and J. Lohmeyer. 1997. Phagocytosis of
viable Candida albicans by alveolar macrophages: lack of opsonin function of
surfactant protein A. J. Infect. Dis. 175:421–428.
52. Roy, C. R., K. H. Berger, and R. R. Isberg. 1998. Legionella pneumophila
DotA protein is required for early phagosome trafficking decisions that occur
within minutes of bacterial uptake. Mol. Microbiol. 28:663–674.
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring
Harbor, N.Y.
54. Schiff, D. E., L. Kline, K. Soldau, J. D. Lee, J. Pugin, P. S. Tobias, and R. J.
Ulevitch. 1997. Phagocytosis of gram-negative bacteria by a unique CD14-
dependent mechanism. J. Leukocyte Biol. 62:786–794.
55. Schlesinger, L. S., and M. A. Horwitz. 1991. Phenolic glycolipid-1 of Myco-
bacterium leprae binds complement component C3 in serum and mediates
phagocytosis by human monocytes. J. Exp. Med. 174:1031–1038.
56. Segal, G., M. Purcell, and H. A. Shuman. 1998. Host cell killing and bacterial
conjugation require overlapping sets of genes within a 22-kb region of the
Legionella pneumophila genome. Proc. Natl. Acad. Sci. USA 95:1669–1674.
57. Shewen, P. E., and B. N. Wilkie. 1982. Cytotoxin of Pasteurella haemolytica
acting on bovine leukocytes. Infect. Immun. 35:91–94.
58. Stone, B. J., and Y. Abu Kwaik. 1998. Expression of multiple pili by
Legionella pneumophila: identification and characterization of a type IV
pilin gene and its role in adherence to mammalian and protozoan cells.
Infect. Immun. 66:1768–1775.
59. Taichman, N. S., D. L. Simpson, S. Sakurada, M. Cranfield, J. DiRienzo,
and J. Slots. 1987. Comparative studies on the biology of Actinobacillus
actinomycetemcomitans leukotoxin in primates. Oral Microbiol. Immunol.
2:97–104.
60. Tsai, C. C., B. J. Shenker, J. M. DiRienzo, D. Malamud, and N. S. Taichman.
1984. Extraction and isolation of a leukotoxin from Actinobacillus actinomy-
cetemcomitans with polymyxin B. Infect. Immun. 43:700–705.
61. Vogel, J. P., H. L. Andrews, S. K. Wong, and R. R. Isberg. 1998. Conjugative
transfer by the virulence system of Legionella pneumophila. Science 279:873–
876.
62. Welch, R. A. 1991. Pore-forming cytolysin of gram-negative bacteria. Mol.
Microbiol. 5:521–528.
63. Wiater, L. A., K. Dunn, F. R. Maxfield, and H. A. Shuman. 1998. Early events
in phagosome establishment are required for intracellular survival of Legio-
nella pneumophila. Infect. Immun. 66:4450–4460.
64. Winn, W. C., Jr., G. S. Davis, D. W. Gump, J. E. Craighead, and H. N. Beaty.
1982. Legionnaires’ pneumonia after intratracheal inoculation of guinea pigs
and rats. Lab. Investig. 47:568–578.
65. Winn, W. C., Jr., and R. L. Myerowitz. 1981. The pathology of Legionella
pneumonias: a review of 74 cases and the literature. Hum. Pathol. 12:401–
422.
66. Wintermeyer, E., U. Rdest, B. Ludwig, A. Debes, and J. Hacker. 1991.
Characterization of legiolysin (lly), responsible for haemolytic activity, colour
production and fluorescence of Legionella pneumophila. Mol. Microbiol.
5:1135–1143.
67. Zuckman, D. M., J. B. Hung, and C. R. Roy. 1999. Pore-forming activity is
not sufficient for Legionella pneumophila phagosome trafficking and intra-
cellular growth. Mol. Microbiol. 32:990–1001.
Editor: J. D. Clements
VOL. 69, 2001 L. PNEUMOPHILA rtxA 517
